Mark A. Jenkins

38.6k citations

318 papers · 10.5k indexed · 1 hit paper · h-index 54

Impact in

Pathology and Forensic Medicine top 0.1%
- Genetic factors in colorectal cancer
Oncology top 0.5%
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Treatments and Studies
- Global Cancer Incidence and Screening

Papers in

Pathology and Forensic Medicine 163
- Genetic factors in colorectal cancer 161
Oncology 161
- Colorectal Cancer Screening and Detection 121
- Colorectal Cancer Treatments and Studies 30
- Global Cancer Incidence and Screening 26

Co-authors: John L. Hopper Graham G. Giles Aung Ko Win Noralane M. Lindor Melissa C. Southey Daniel D. Buchanan Joanne Young John B. Carlin
Journals: Cancer Epidemiology Biomarkers & Prevention (25 papers)Familial Cancer (16 papers)International Journal of Cancer (15 papers)Human Mutation (9 papers)Journal of Clinical Oncology (8 papers)
Partner nations: Australia United States Canada

In The Last Decade

Mark A. Jenkins

300 papers receiving 10.2k citations

Hit Papers

align trajectories log scale

Global trends in colorectal cancer mortality: projections to the year 2035 2018 · 389 citations

Peers

Countries citing papers authored by Mark A. Jenkins

Since Specialization

Citations

This map shows the geographic impact of Mark A. Jenkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Jenkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Jenkins more than expected).

Fields of papers citing papers by Mark A. Jenkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Jenkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Jenkins. The network helps show where Mark A. Jenkins may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. Jenkins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Jenkins Line = papers co-authored together Mark A. Jenkins links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Optimising invitation and advance notification letters to increase bowel cancer screening participation: A qualitative analysis Patient Education and Counseling ·麻理子小倉, Michael Ireland, L. E. Anderson, Carlene Wilson, 于小园, Shvan Ahmed Abduqader Alaziz, Mark A. Jenkins, Belinda C. Goodwin	2025	1
2	The effect and psychological mediators of a redesigned invitation letter to increase bowel cancer screening intention and likelihood: A randomised controlled experiment Patient Education and Counseling ·麻理子小倉, Michael Ireland, 郁子新垣, Mark A. Jenkins, Jennifer McIntosh, Eleonora Feletto, Nancy N. Baxter, Belinda C. Goodwin	2025	0
3	Using DEPendency of Association on the Number of Top Hits (DEPTH) as a Complementary Tool to Identify Novel Colorectal Cancer Susceptibility Loci Cancer Epidemiology Biomarkers & Prevention ·John Lai, L. DICICCO, Daniel F. Schmidt, 敏高木, D. Q. Li, Robert J. MacInnis, Daniel D. Buchanan, Aung Ko Win, Jane C. Figueiredo, Andrew T. Chan, Tabitha A. Harrison, Michael Hoffmeister, Emily White, Loı̈c Le Marchand, Rish K. Pai, Ulrike Peters, John L. Hopper, Mark A. Jenkins, Enes Makalic	2023	0
4	An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic Asia-Pacific Journal of Clinical Oncology ·Koen Degeling, Nancy N. Baxter, Jon Emery, Mark A. Jenkins, Fanny Franchini, Peter Gibbs, G. Bruce Mann, Grant A. McArthur, Benjamin Solomon, Maarten J. IJzerman	2021	56
5	Tetranucleotide and Low Microsatellite Instability Are Inversely Associated with the CpG Island Methylator Phenotype in Colorectal Cancer Cancers ·Takesh Kodaka, Nicola Currey, John Patrick Mccracken, Corey Jermaine Henderson, Mark A. Jenkins, Daniel D. Buchanan, John L. Hopper, Eva Segelov, Jane E. Dahlstrom, Maija R.J. Kohonen‐Corish	2021	5
6	A New Comprehensive Colorectal Cancer Risk Prediction Model Incorporating Family History, Personal Characteristics, and Environmental Factors Cancer Epidemiology Biomarkers & Prevention ·Yingye Zheng, Xinwei Hua, Aung Ko Win, Robert J. MacInnis, Steven Gallinger, Loı̈c Le Marchand, Noralane M. Lindor, John A. Baron, John L. Hopper, James G. Dowty, Antonis C. Antoniou, Jiayin Zheng, Mark A. Jenkins, Polly A. Newcomb	2020	25
7	A general framework for functionally informed set-based analysis: Application to a large-scale colorectal cancer study PLoS Genetics ·Xinyuan Dong, Yu‐Ru Su, Richard Barfield, Stephanie A. Bien, Qianchuan He, Tabitha A. Harrison, Jeroen R. Huyghe, Temitope O. Keku, Noralane M. Lindor, Clemens Schafmayer, Andrew T. Chan, Stephen B. Gruber, Mark A. Jenkins, Charles Kooperberg, Ulrike Peters, Li Hsu	2020	10
8	SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT -Methylated Colorectal Cancer Clinical Cancer Research ·E.V. Chumak, Fan Wang, Robert W. Rapkins, Robyn L. Ward, Daniel D. Buchanan, Aung Ko Win, Mark Clendenning, Christophe Rosty, Melissa C. Southey, Ingrid Winship, John L. Hopper, Mark A. Jenkins, Jake Olivier, Nicholas J. Hawkins, Megan P. Hitchins	2016	20
9	Childhood body mass index and adult mammographic density measures that predict breast cancer risk Breast Cancer Research and Treatment ·John L. Hopper, Tuong L. Nguyen, Jennifer Stone, Bonamente Aliprandi, Melanie C. Matheson, Michael J. Abramson, John A. Burgess, E. Haydn Walters, Gillian S. Dite, Minh Bui, Chris Evans, Enes Makalic, Daniel F. Schmidt, Shu ShunShun, Mark A. Jenkins, Graham G. Giles, Shyamali C. Dharmage, Carmel Apicella	2016	21
10	Accuracy of Self-Reported Nevus and Pigmentation Phenotype Compared with Clinical Assessment in a Population-Based Study of Young Australian Adults Cancer Epidemiology Biomarkers & Prevention ·Anne Ε. Cust, Kristen Pickles, Chris Goumas, Marius Klaus, Helen Schmid, Eduardo Nagore, John W. Kelly, Joanne F. Aitken, Graham G. Giles, John L. Hopper, Mark A. Jenkins, Graham J. Mann	2015	12
11	Prediagnostic Physical Activity and Colorectal Cancer Survival: Overall and Stratified by Tumor Characteristics Cancer Epidemiology Biomarkers & Prevention ·Sheetal Hardikar, Polly A. Newcomb, Peter T. Campbell, Aung Ko Win, Noralane M. Lindor, Daniel D. Buchanan, Karen W. Makar, Mark A. Jenkins, John D. Potter, Amanda I. Phipps	2015	30
12	1054 Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH European Journal of Cancer ·Aung Ko Win, Teresa De Porras‐Carrique, James G. Dowty, Daniel D. Buchanan, Mark Clendenning, Juan I. Young, Sean P. Cleary, Michelle Cotterchio, Peter Warrén, Jeffrey Baron, Loı̈c Le Marchand, G. Casey, R. W. Haile, Polly A. Newcomb, S. N. Thibodeau, JL Hopper, Steve Gallinger, Ingrid Winship, Noralane M. Lindor, Mark A. Jenkins	2015	9
13	Short-Term Risk of Colorectal Cancer in Individuals With Lynch Syndrome: A Meta-Analysis Journal of Clinical Oncology ·Mark A. Jenkins, James G. Dowty, Driss Ait Ouakrim, John D. Mathews, John L. Hopper, Youenn Drouet, Christine Lasset, Valérie Bonadona, Aung Ko Win	2014	24
14	Genitourinary Laboratory Investigation ·Christophe Rosty, Michael D. Walsh, Mark Clendenning, Joanne Young, X.G. Zhang, 生島義久, Mark A. Jenkins, Gui-yu 朴桂玉Piao, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2013	1
15	Population-Based Estimate of Prostate Cancer Risk for Carriers of the HOXB13 Missense Mutation G84E PLoS ONE ·Robert J. MacInnis, Gianluca Severi, Laura Baglietto, James G. Dowty, Mark A. Jenkins, Melissa C. Southey, John L. Hopper, Graham G. Giles	2013	29
16	Genetic Variation in the Vitamin D Receptor ( VDR ) and the Vitamin D–Binding Protein ( GC ) and Risk for Colorectal Cancer: Results from the Colon Cancer Family Registry Cancer Epidemiology Biomarkers & Prevention ·Jenny N. Poynter, Elizabeth T. Jacobs, Jane C. Figueiredo, M. V. Planelles-Ramos, David V. Conti, Peter T. Campbell, 安敏山口, Paul J. Limburg, Loı̈c Le Marchand, Michelle Cotterchio, Polly A. Newcomb, John D. Potter, Mark A. Jenkins, John L. Hopper, David Duggan, John A. Baron, Robert W. Haile	2010	51
17	Constitutional Methylation of the BRCA1 Promoter Is Specifically Associated with BRCA1 Mutation-Associated Pathology in Early-Onset Breast Cancer Cancer Prevention Research ·Ee Ming Wong, Melissa C. Southey, Stephen B. Fox, Melissa A. Brown, James G. Dowty, Mark A. Jenkins, Graham G. Giles, John L. Hopper, Alexander Dobrovic	2010	120
18	Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma Pigment Cell & Melanoma Research ·Anne Ε. Cust, Bruce K. Armstrong, Chris Goumas, Mark A. Jenkins, Helen Schmid, John L. Hopper, Richard Kefford, Graham G. Giles, Joanne F. Aitken, Graham J. Mann	2010	4
19	Germline MutY Human Homologue Mutations and Colorectal Cancer: A Multisite Case-Control Study Gastroenterology ·Sean P. Cleary, Michelle Cotterchio, Mark A. Jenkins, Hyeja Kim, Robert G. Bristow, Roger Green, Robert W. Haile, John L. Hopper, Loı̈c Le Marchand, Noralane M. Lindor, Patrick S. Parfrey, John D. Potter, Ban Younghusband, Steven Gallinger	2008	153
20	After hMSH2 and hMLH1—what next? Analysis of three‐generational, population‐based, early‐onset colorectal cancer families International Journal of Cancer ·Mark A. Jenkins, Laura Baglietto, Gillian S. Dite, Damien John Jolley, Melissa C. Southey, Simón Pedro Izcara Palacios, Leeanne J. Mead, David John, Finlay Macrae, D. Timothy Bishop, Deon J. Venter, Graham G. Giles, John L. Hopper	2002	31

About Mark A. Jenkins

Mark A. Jenkins is a scholar working on Pathology and Forensic Medicine, Oncology, Cancer Research, Genetics and Immunology and Allergy, having authored 318 papers that have together received 10.5k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (161 papers), Colorectal Cancer Screening and Detection (121 papers), Cancer Genomics and Diagnostics (52 papers), BRCA gene mutations in cancer (45 papers), Colorectal Cancer Treatments and Studies (30 papers), Global Cancer Incidence and Screening (26 papers), Multiple and Secondary Primary Cancers (19 papers) and Genetic Associations and Epidemiology (17 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.9k citations), Oncology (4.4k citations), Cancer Research (2.0k citations), Immunology and Allergy (553 citations) and Genetics (1.7k citations). Mark A. Jenkins has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include John L. Hopper, Graham G. Giles, Aung Ko Win, Noralane M. Lindor, Melissa C. Southey, Daniel D. Buchanan, Joanne Young, John B. Carlin, Mark Clendenning and Polly A. Newcomb. Their work appears in journals such as Cancer Epidemiology Biomarkers & Prevention, Familial Cancer, International Journal of Cancer, Human Mutation and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact